Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
about
Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb ActivationEffect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.Short Communication: HIV-1 Variants That Use Mouse CCR5 Reveal Critical Interactions of gp120's V3 Crown with CCR5 Extracellular Loop 1Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agentsAccurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.HIV coreceptor tropism determination and mutational pattern identification.A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART.Conserved molecular mechanisms underlying the effects of small molecule xenobiotic chemotherapeutics on cells.Effect of Amino Acid Substitutions Within the V3 Region of HIV-1 CRF01_AE on Interaction with CCR5-Coreceptor.Processing, fusogenicity, virion incorporation and CXCR4-binding activity of a feline immunodeficiency virus envelope glycoprotein lacking the two conserved N-glycosylation sites at the C-terminus of the V3 domain.Computational study on the interaction between CCR5 and HIV-1 entry inhibitor maraviroc: insight from accelerated molecular dynamics simulation and free energy calculation.Pressuromodulation at the cell membrane as the basis for small molecule hormone and peptide regulation of cellular and nuclear functionProtein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism.
P2860
Q28546901-C7339C0B-525E-46FC-9EC8-17142522B86FQ35580330-3C03753A-C507-4DF0-8107-BA1D01611460Q36078450-BAB17647-6EC1-41B7-8D7E-1724EC0309A4Q36181993-2EB14000-EE5D-4B8C-88D2-56F4E188ED9CQ36337888-160AA23C-10E1-49F1-B861-2FCC404F622DQ36588528-1D27B48A-71D3-45E8-A41E-0813DD25ED2DQ37517645-CE4041CC-39BB-4FBA-A72E-7F9F0D917C2DQ37642937-06423AD9-7986-4965-8D9E-4A078A68A0BDQ38719813-C3D15DF8-05AC-4BD4-9C2C-A83F5AC9E530Q40204210-0BDA4E75-EB16-47D2-812C-3DEF2D80A06FQ40830461-91E8B64E-6778-40E6-9DC3-A215F55149DEQ41710572-6F98BC9C-A19C-4F73-8495-BEDA342CC7C8Q42153567-01621468-91C3-48ED-BFDD-5790CAA31C86Q45326031-B57FCD7D-7B38-4613-8F46-73521670C01D
P2860
Modelling binding between CCR5 and CXCR4 receptors and their ligands suggests the surface electrostatic potential of the co-receptor to be a key player in the HIV-1 tropism.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@en
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@nl
type
label
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@en
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@nl
prefLabel
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@en
Modelling binding between CCR5 ...... y player in the HIV-1 tropism.
@nl
P2860
P50
P356
P1433
P1476
Modelling binding between CCR5 ...... ey player in the HIV-1 tropism
@en
P2093
Olga V Kalinina
P2860
P2888
P356
10.1186/1742-4690-10-130
P577
2013-11-11T00:00:00Z
P5875
P6179
1044920398